GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $972,000 | +206.6% | 27,800 | +126.0% | 0.00% | – |
| Q3 2021 | $317,000 | -55.9% | 12,300 | -44.5% | 0.00% | – |
| Q2 2021 | $719,000 | -62.0% | 22,160 | -52.3% | 0.00% | -100.0% |
| Q1 2021 | $1,893,000 | -42.0% | 46,461 | -37.0% | 0.00% | -33.3% |
| Q4 2020 | $3,266,000 | +17.2% | 73,784 | +42.8% | 0.01% | 0.0% |
| Q3 2020 | $2,787,000 | -28.8% | 51,667 | -31.3% | 0.01% | -45.5% |
| Q1 2020 | $3,912,000 | +30.7% | 75,172 | +98.8% | 0.01% | +57.1% |
| Q4 2019 | $2,992,000 | +64.4% | 37,809 | +2.4% | 0.01% | +40.0% |
| Q3 2019 | $1,820,000 | -36.7% | 36,932 | -32.5% | 0.01% | -37.5% |
| Q2 2019 | $2,877,000 | -3.7% | 54,695 | -3.1% | 0.01% | 0.0% |
| Q1 2019 | $2,988,000 | -24.4% | 56,460 | -42.9% | 0.01% | -27.3% |
| Q4 2018 | $3,954,000 | +31.4% | 98,795 | +24.7% | 0.01% | +57.1% |
| Q3 2018 | $3,010,000 | – | 79,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |